Video

Dr. Markman on Potential Neuropathy Biomarkers

Author(s):

Maurie Markman, MD

In Partnership With:

Dr. Markman on Taxane-Induced Neuropathy Biomarkers

Maurie Markman, MD the National Director for Medical Oncology for the Cancer Treatment Centers of America on Taxane-Induced Neuropathy Biomarkers

Related Videos
Bradley C. Carthon, MD, PhD
David C. Fisher, MD
Alan Tan, MD
Binod Dhakal, MD
Sheldon M. Feldman, MD
Yair Lotan, MD, UT Southwestern Medical Center
Alan Tan, MD, Vanderbilt-Ingram Cancer Center
Alex Herrera, MD
Roy S. Herbst, MD, PhD
Sheldon M. Feldman, MD
Related Content
Alex F. Herrera, MD
October 25th 2024

Nivolumab Plus AVD Prolongs PFS vs Brentuximab Vedotin Plus AVD in Advanced-Stage Hodgkin Lymphoma

Ravi Salgia, MD, PhD, professor, chair, Department of Medical Oncology & Therapeutics Research, Arthur & Rosalie Kaplan Chair in Medical Oncology & Therapeutics Research, City of Hope
September 2nd 2024

Salgia Summarizes the Benefits of Tepotinib in MET Exon 14–Mutated NSCLC

Myo Htut, MD, of City of Hope
October 1st 2024

BMS-986393 Shows First-In-Class Potential in Relapsed/Refractory Multiple Myeloma

Oncology Unplugged
August 21st 2024

Park and Kasi Expand on Perioperative Immunotherapy Updates in CRC

Danny Nguyen, MD
September 23rd 2024

BDTX-1535 Generates Early Signals of Antitumor Activity in R/R EGFR+ NSCLC

The OncFive: Top Oncology Articles for the Week of 9/1
September 7th 2024

The OncFive: Top Oncology Articles for the Week of 9/1